The purpose of this clinical study is to test whether or not patients treated with HBOT for
diabetic foot ulcers will demonstrate measurable changes of the blood vessel function during
the course of HBOT treatments. , i.e. an expected increase in the reactive hyperemic index
(RHI) measured by the peripheral arterial tonometry (PAT).